Webcast ImageWebcast
Q1 2014 Incyte Corporation Earnings Conference Call (Live)
05/01/14 at 8:30 a.m. ET
Q1 2014 Incyte Corporation Earnings Conference Call
Thursday, May 1, 2014 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
INCY (Common)
Exchange   NASDAQ Change   + 0.56 (1.27%)
Price   $44.54 Volume  3,681,855
Last Trade   April 17, 2014 | 4:00 p.m. ET

Corporate Profile

Incyte's vision is to become a leading drug discovery, development and commercial company by building a proprietary product pipeline of novel small molecule drugs for serious unmet medical needs. We have experienced management, discovery, clinical development and commercial teams. Our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference in health care, improve the lives of patients and build sustainable value for our shareholders.


Recent News More >>
DateTitle 
April 16, 2014Incyte to Report First Quarter 2014 Financial Results on May 1
WILMINGTON, Del.--(BUSINESS WIRE)--Apr. 16, 2014-- Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its first quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, May 1, 2014. The schedules for the press release and conference call are as follows:         ... 
Printer Friendly Version
March 07, 2014Incyte Announces Positive Top-Line Results from Phase III Study of Ruxolitinib in Patients with Polycythemia Vera
Study of ruxolitinib versus best available therapy for patients with polycythemia vera who are resistant to or intolerant of hydroxyurea met primary endpoint Ruxolitinib is the first selective JAK1/JAK2 inhibitor to demonstrate efficacy in a Phase III trial for treating polycythemia vera Data expected to be presented at an upcoming scientific meeting Supplemental new drug application pl... 
Printer Friendly Version
February 18, 2014Incyte to Present at Upcoming Investor Conferences
WILMINGTON, Del.--(BUSINESS WIRE)--Feb. 18, 2014-- Incyte Corporation (Nasdaq:INCY) announced today it will present at the following investor conferences during the month of March: Cowen and Company 34th Annual Health Care Conference on Monday, March 3, 2014 at 2:10 pm (EST) in Boston; and Barclays Capital Global Healthcare Conference on Tuesday, March 11, 2014 at 11:15 am (EST) in Miami The ... 
Printer Friendly Version

2012 Annual Report
2012 Annual Report Download Documentation

2012 10-K

Notice To Readers: Incyte's press releases, presentations and printed remarks are included on this Web site for historical purposes only. The information contained in these documents and webcasts should be considered accurate only as of the date of the relevant document or presentation. This information may change over time; therefore, visitors to this Web site should not assume that the information contained in these documents or presentations remains accurate at a later time. We do not have any current intention, and expressly disclaim any obligation, to supplement, update or revise any of the information in these documents or presentations.


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.